早期肝细胞癌快速生长的CT和MRI相关因素
回顾性分析2016年1月至2020年12月322例患者345个经手术证实的早期肝细胞癌,评估各LI-RADS类别中快速生长(肿瘤体积倍增时间<3个月)的比例并寻找相关因素。结果显示LR-M类中70%表现为快速生长,LR-M类别、甲胎蛋白>400 ng/mL及基线肿瘤直径较小与快速生长独立相关。
要点
- 早期肝细胞癌中LR-M类别与快速生长独立相关,70%的LR-M病灶表现为快速生长(TVDT<3个月)。
- 甲胎蛋白>400 ng/mL与快速生长独立相关(校正OR 2.54,95%CI 1.16-5.54,P=.02)。
- 基线肿瘤直径较小与快速生长独立相关(校正OR 0.65,95%CI 0.48-0.87,P=.004)。
核心结论
- 在早期肝细胞癌中,LR-M类别是快速生长的独立因素,70%的LR-M病灶表现为快速生长。
研究设计与样本
- 回顾性研究纳入具有肝细胞癌危险因素且经手术证实为早期肝细胞癌的患者,2016年1月至2020年12月期间接受两次或以上术前多期CT或MRI检查;共322例患者(平均年龄61岁±9[SD],249例男性)的345个肝细胞癌病灶(LR-3 30个、LR-4 64个、LR-5 221个、LR-M 30个)。
诊断标准与关键数值
- 根据基线CT或MRI结果进行LI-RADS分类;肿瘤体积倍增时间(TVDT)由两次检查测量的肿瘤体积计算;生长速度分类为快速(TVDT<3个月)、中等(TVDT=3-9个月)或惰性(TVDT>9个月);345个肝细胞癌的中位TVDT为131天(IQR 87-233),27.0%的肝细胞癌表现为快速生长;快速生长比例LR-M 70.0% vs LR-3 3.3%(P<.001)、LR-M 70.0% vs LR-4 12.5%(P<.001)、LR-M 70.0% vs LR-5 28.5%(P<.001);甲胎蛋白>400 ng/mL与快速生长独立相关(校正OR 2.54,95%CI 1.16-5.54,P=.02);基线肿瘤直径与快速生长独立相关(校正OR 0.65,95%CI 0.48-0.87,P=.004);LR-M类别与快速生长独立相关(校正OR 9.26,95%CI 3.70-23.16,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prediction of the tumor growth rates is clinically important in patients with hepatocellular carcinoma (HCC), but previous studies have presented conflicting results and generally lacked radiologic evaluations. Purpose To evaluate the percentage of rapidly growing early-stage HCCs in each Liver Imaging Reporting and Data System (LI-RADS) category and to identify prognostic factors associated with rapid growth. Materials and Methods Retrospective study of patients with risk factors for HCC and those with surgically proven early-stage HCC who underwent two or more preoperative multiphasic CT or MRI examinations between January 2016 and December 2020. LI-RADS categories were assigned according to the baseline CT or MRI results. The tumor volume doubling time (TVDT) was calculated from the tumor volumes measured at the two examinations. The growth rate was classified as rapid (TVDT < 3 months), intermediate (TVDT = 3-9 months), or indolent (TVDT > 9 months). The percentage of rapidly growing HCCs was compared among the LI-RADS categories, and multivariable logistic regression was used to identify factors associated with rapidly growing HCC. Results In 322 patients (mean age, 61 years ± 9 [SD]; 249 men) with 345 HCCs (30 LR-3, 64 LR-4, 221 LR-5, and 30 LR-M category), the median TVDT of HCC was 131 days (IQR, 87-233) and 27.0% of HCCs showed rapid growth. The growth rates differed among the LI-RADS categories, with a higher percentage of rapidly growing HCCs observed for LR-M HCCs than for LR-3 (70.0% vs 3.3%, P < .001), LR-4 (70.0% vs 12.5%, P < .001), or LR-5 (70.0% vs 28.5%, P < .001) HCCs. An α-fetoprotein level greater than 400 ng/mL (adjusted odds ratio [OR], 2.54; 95% CI: 1.16, 5.54; P = .02), baseline tumor diameter (adjusted OR, 0.65; 95% CI: 0.48, 0.87; P = .004), and LR-M category (adjusted OR, 9.26; 95% CI: 3.70, 23.16; P < .001) were independently associated with higher odds of rapid growth. Conclusion Among early-stage HCCs, LR-M category was an independent factor for rapid growth, observed in 70% of HCCs. © RSNA, 2024 Supplemental material is available for this article.
引用
- Jang HJ, Choi SH, Wee S, et al. CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma. Radiology. 2024. PMID: 39718496. doi:10.1148/radiol.240961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。